Biological Activity Cagrilintide and semaglutide, when co-administered, produce synergistic reductions in bodyweight (up to ~1517% over 2032 weeks in clinical trials) and significant improvements in glycemic parameters, including HbA1c and fasting glucose
Most people should plan on weeks to a few months of consistent use before judging GHK-Cu, since it works by gradually rebuilding tissue rather than producing an instant change
Peptides interact with universal biological pathways (e.g., healing, GH release)
Patients considering weight loss injections after bariatric surgery should initiate this conversation with their bariatric surgery team rather than pursuing these medications independently through primary care or weight loss clinics unfamiliar with their surgical history
Ensure the healthy functioning and repair of cellular DNA (genetic material)
This is known as "referred" pain